Inactive
Notice ID:36C24624Q0201
DISCLAIMER: THIS NOTICE IS FOR PLANNING PURPOSES ONLY. THE GOVERNMENT DOES NOT INTEND TO AWARD A CONTRACT ON THE BASIS OF THIS RFI OR REIMBURSE ANY COSTS ASSOCIATED WITH THE PREPARATION OF RESPONSES T...
DISCLAIMER: THIS NOTICE IS FOR PLANNING PURPOSES ONLY. THE GOVERNMENT DOES NOT INTEND TO AWARD A CONTRACT ON THE BASIS OF THIS RFI OR REIMBURSE ANY COSTS ASSOCIATED WITH THE PREPARATION OF RESPONSES TO THIS RFI. This RFI is issued solely for information and planning purposes and does not constitute a Solicitation, an Invitation for Bids, a Request for Proposal (RFP), a Request for Quotation (RFQ), or an indication the Government will contract for the items contained in this announcement. All information received in response to this RFI marked Proprietary will be handled accordingly. Responses to the RFI will not be returned. In accordance with FAR 15.201(e), responses to this RFI are not offers and cannot be accepted by the Government to form a binding contract. PURPOSE: The purpose of this RFI is to conduct market research to find qualified vendors and to assist Network Contracting Office (NCO) 6 in determining if a future contract effort can be competitively awarded on a Brand Name or Equal, Unrestricted Basis. The applicable North American Industrial Classification System (NAICS) code assigned to this effort is 339112 (Surgical and Medical Instrument Manufacturing) with the Small Business Size Standard of 1000 Employees. If the Government determines there are qualified vendors for this requirement, a solicitation will be published and posted on the Contracting Opportunities website. The Government will use this information solely to determine the appropriate acquisition strategy for this procurement. INTRODUCTION: This requirement is for the purchase of BioDFence G3 Resorbable Adhesion Barrier (Brand Name or Equal). The Contractor shall provide all labor, material, supplies, management, and supervision necessary to provide the delivery of the items for the Hampton VAMC, located at 100 Emancipation Drive, Hampton, VA 23667. The government encourages all vendors that can meet or exceed the item descriptions below to respond to this source sought. If providing a like item/system, please include attachments, information, and part numbers to allow the government to assess whether your items/system will suffice for this requirement. Manufacturer: INTEGRA LIFESCIENCES CORPORATION PRODUCT NUMBER PRODUCT DESCRIPTION QTY UNIT DF-020404 BIODFENCE G3 RESORBABLE ADHESION BARRIER 4X4 CM2 3 EA DF-020306 BIODFENCE G3 RESORBABLE ADHESION BARRIER 3X6 CM2 3 EA DF-020408 BIODFENCE G3 RESORBABLE ADHESION BARRIER 4X8 CM2 3 EA DF-020606 BIODFENCE G3 RESORBABLE ADHESION BARRIER 6X6 CM2 3 EA Salient Characteristics: Three-Layer Structure: BioD G3 Amniotic Membrane is a placental tissue allograft that consists of three distinct layers: the amnion, chorion, and amnion layers. This intricate layered structure is pivotal to its therapeutic properties, allowing for optimal tissue integration and regeneration. Dryflex Processing: Utilizing proprietary Dryflex processing, BioD G3 Amniotic Membrane maintains the integrity and bioactivity of essential growth factors, cytokines, and the extracellular matrix found in native placental tissue. This preservation is critical for achieving optimal therapeutic outcomes. Sterilization: Rigorous terminal sterilization procedures are employed during the manufacturing process to ensure the highest standards of product safety and sterility. This safeguards against the risk of infections, making it suitable for use in a clinical setting. Extended Shelf Life: BioD G3 Amniotic Membrane offers an impressive five-year shelf life when stored at room temperature. This extended shelf life enhances convenience and ensures product availability when needed most. Bioactive Growth Factors: Notably, this product contains a higher concentration of bioactive growth factors compared to many other options available. These growth factors play a pivotal role in promoting tissue regeneration and accelerating wound healing. Wound Healing: BioD G3 Amniotic Membrane is specifically engineered to create an ideal environment for wound healing. Its efficacy in promoting the closure of complex wounds has been well-established, making it an invaluable asset in the field of wound care. Versatile Application: There are no specific limitations on the application of BioD G3 Amniotic Membrane. Its versatility allows for its use in a wide range of medical procedures and across various wound types. Ease of Handling: The product is thoughtfully designed for ease of handling, simplifying procedures for healthcare professionals and contributing to efficient clinical workflows. Vendors with a GSA schedule shall provide the contract number of that schedule and the expiration date as well as product NAICS codes. All items should be clearly identified if they are scheduled items or open market items. HOW TO RESPOND: All responses shall be submitted no later than December 11, 2023 @ 2:00 PM EST. All interested parties should respond, in writing via email to kenneca.crump@va.gov. No telephone inquiries will be accepted. Respondents to this RFI shall provide the following information: Company/individual name, Address, Point of contact with phone number Information describing your interest, Indicate FSS/GSA contract number or Open Market, as applicable FSS Category you qualify for Tax ID number DUNS number Unique Entity ID (UEI) (SAM) Capabilities statement Company Socio-Economic SIZE (example large, small, SDVOSB, VOSB, WOSB etc.) If you are not the Original Equipment Manufacturer (OEM) please provide proof of being an Authorized Distributor by submission of a copy of your Authorized Distributor Letter. Interested firms are reminded that in accordance with FAR 4.1201(a) Prospective contractors shall complete electronic annual representations and certifications at the System for Award Management (SAM) as a part of required registration in conjunction with FAR 4.1102(a) that states, Prospective contractors shall be registered in the (SAM) database prior to award of a contract or agreement. Therefore, due to time constraints, vendors must be registered in System for Award Management (SAM) under the above NAICS code at http://www.sam.gov to be considered for an award. Please submit responses via email to Kenneca.Crump@va.gov in Microsoft Office/PDF format by 2:00 PM (Eastern Standard Time) 12/11/2023. Please include RFI# 36C24624Q0201in subject title. NOTE: Responses to this announcement will not be returned, nor will there be any ensuing discussions or debriefings of any responses. However, information obtained as a result of this announcement may be reflected in any subsequent solicitation. This announcement is Government market research purposes ONLY.
